Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	09-2020	06-2020	03-2020	12-2019
Assets
Current Assets
Cash & Cash Equivalents	333,558	339,439	363,511	286,649	171,160
Marketable Securities	102,947	96,392	130,532	224,621	118,955
Receivables	1,829	2,585	49	N/A	N/A
Inventories	5,876	3,976	778	N/A	N/A
TOTAL	$450,003	$450,105	$502,771	$518,441	$296,602

Non-Current Assets
PPE Net	17,499	14,843	13,695	13,967	14,755
Intangibles	218,307	219,354	31,660	32,334	0
Other Non-Current Assets	34,411	27,845	28,055	28,185	28,930
TOTAL	$270,217	$262,042	$73,410	$74,486	$43,685

Total Assets	$720,220	$712,147	$576,181	$592,927	$340,287

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	12,657	7,860	6,603	8,709	8,010
Accrued Expenses	32,938	37,659	22,245	16,178	18,636
Other current liabilities	3,081	3,163	3,101	3,042	2,952
TOTAL	$60,964	$63,653	$47,993	$41,635	$40,979

Non-Current Liabilities
Deferred Revenues	7,851	10,931	12,255	10,079	7,911
Other Non-Current Liabilities	207,672	200,830	198,175	196,195	25,870
TOTAL	$284,966	$275,641	$272,470	$242,917	$73,818

Total Liabilities	$345,930	$339,294	$320,463	$284,552	$114,797

Shareholders' Equity
Shares Outstanding, K	71,378	66,549	65,928	57,052	56,927
Common Shares	69	67	57	57	52
Retained earnings	-1,126,293	-1,047,984	-966,727	-906,137	-844,204
Other shareholders' equity	0	0	117	524	3
TOTAL	$374,290	$372,853	$255,718	$308,375	$225,490

Total Liabilities And Equity	$720,220	$712,147	$576,181	$592,927	$340,287